The next stage for the rollout of the COVID-19 vaccination programme is to vaccinate 5- to 11-year-olds. NHS England told us it recognised that this would probably be a slower and more challenging rollout given the adaptations necessary to accommodate 42 Public Accounts Committee, Oral evidence: Covid-19: Planning for a vaccine, HC 930, 11 January 2021, Qq 28, 66 43 C&AG’s Report, paras 1.10, 2.3 44 Since the session a sixth vaccine, the Valneva COVID-19 vaccine, received approval by MHRA on ...

The next stage for the rollout of the COVID-19 vaccination programme is to vaccinate 5- to 11-year-olds. NHS England told us it recognised that this would probably be a slower and more challenging rollout given the adaptations necessary to accommodate 42 Public Accounts Committee, Oral evidence: Covid-19: Planning for a vaccine, HC 930, 11 January 2021, Qq 28, 66 43 C&AG’s Report, paras 1.10, 2.3 44 Since the session a sixth vaccine, the Valneva COVID-19 vaccine, received approval by MHRA on 14 April 2022 45 C&AG’s Report, paras 4, 2.7, Figure 7 46 Qq 60–61 47 Qq 59–64 48 Qq 26, 59 49 Qq 60, 62 50 Valneva COVID-19 vaccine approved by MHRA on Type: conclusion | Number: 22 | Response status: not_addressed